553 results match your criteria: "Centre cardiologique du Nord[Affiliation]"
Pathogens
November 2024
Department of Cardiac Surgery, Centre Cardiologique du Nord, 93200 Saint-Denis, France.
Prosthetic valve endocarditis (PVE) is the medical term used to describe a focus of infection involving a valvular substitute within the heart. It is a significant concern in the field of cardiology, and the epidemiology of PVE has seen notable developments over the last five decades. The disease currently affects an older demographic and is becoming increasingly prevalent in patients with transcatheter-implanted valves.
View Article and Find Full Text PDFJ Clin Med
December 2024
Department of Cardiac Surgery, Glenfield Hospital, University Hospitals of Leicester, Leicester LE3 9QP, UK.
Secondary mitral regurgitation (SMR) is characterized by a pathological process impacting the left ventricle (LV) as opposed to the mitral valve (MV). In the absence of structural alterations to the MV, the expansion of the LV or impairment of the papillary muscles (PMs) may ensue. A number of technical procedures are accessible for the purpose of determining the optimal resolution for MR.
View Article and Find Full Text PDFJ Geriatr Cardiol
November 2024
Department of Cardiovascular Surgery, Centro Cardiologico Monzino IRCCS, Milan, Italy.
Objective: To evaluate the benefits of surgical repair acute type A aortic dissection (ATAAD) on survival of octogenarians.
Methods: Patients who underwent surgery for acute ATAAD from the multicenter European Registry of Type A Aortic Dissection (ERTAAD) were the subjects of the present analysis.
Results: 326 (8.
Arch Cardiovasc Dis
November 2024
Inserm U1011-EGID, CHU de Lille, Institut Pasteur de Lille, université de Lille, 59000 Lille, France; Centre de simulation en santé PRESAGE, faculté de médecine, université de Lille, 59045 Lille, France.
JACC Cardiovasc Interv
December 2024
Division of Cardiology, Department of Medicine, Glen Hospital, McGill University Health Center, Montreal, Quebec, Canada. Electronic address:
Despite the challenges associated with periprocedural imaging, transcatheter tricuspid valve interventions have shown important impact on outcomes. A comprehensive understanding of the anatomy of the right heart and surrounding structures is crucial. One way to optimize these interventions is by identifying the optimal fluoroscopic viewing angles along the S-curve of the tricuspid valve.
View Article and Find Full Text PDFArch Cardiovasc Dis
November 2024
Cardiology Department, Hôpital Rangueil, CHU de Toulouse, 31400 Toulouse, France; Inserm UMR 1297, I2MC, 31432 Toulouse, France.
JAMA
November 2024
Université de Rennes, CHU Rennes, Service de pharmacologie clinique, Rennes, France.
Importance: Correction of tricuspid regurgitation using tricuspid transcatheter edge-to-edge repair (T-TEER) in addition to guideline-directed optimized medical therapy (OMT) may improve clinical outcomes.
Objective: To evaluate the efficacy of T-TEER + OMT vs OMT alone in patients with severe, symptomatic tricuspid regurgitation.
Design, Setting, And Participants: Investigator-initiated, prospective, randomized (1:1) trial evaluating T-TEER + OMT vs OMT alone in adult patients with severe, symptomatic tricuspid regurgitation.
Biomimetics (Basel)
November 2024
Department of Cardiac Surgery, Centre Cardiologique du Nord, 93200 Saint-Denis, France.
Despite offering several potential benefits over standard prosthetic aortic valve replacement, the use of the pulmonary autograft has been limited to date due to concerns over the risk of pulmonary autograft expansion and the need for reintervention. Several techniques using materials with biomimetic potential have been developed to reduce this complication. The incidence, risk factors, and pathophysiology of pulmonary autograft dilatation are discussed in this article.
View Article and Find Full Text PDFEchocardiography
November 2024
Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Eur Heart J Case Rep
November 2024
Research Center Department, Montreal Heart Institute, 5000 Rue Bélanger, Montréal, QC H1T 1C8, Canada.
Background: The rise of transcatheter tricuspid valve implantation (TTVI) therapies represents a major advancement for high-risk patients with severe tricuspid valve regurgitation, offering a safer, minimally invasive alternative to open-heart surgery. However, the low volume of procedures and training highlights an urgent need for skills development and pre-procedural preparation, which simulation can address by enhancing learning and expanding treatment availability.
Case Summary: An 87-year-old woman with permanent atrial fibrillation and symptomatic severe functional tricuspid regurgitation underwent a transcatheter tricuspid valve replacement with the LuX-Valve system.
J Thorac Cardiovasc Surg
November 2024
Department of Cardiovascular Surgery, Centro Cardiologico Monzino IRCCS, Milan, Italy.
Background: The current study aims to report the presentation of the malperfusion syndrome in patients with acute type A aortic dissection admitted to surgery and its impact on mortality.
Methods: Data were retrieved from the multicenter European Registry of Type A Aortic Dissection. The Penn classification was used to categorize malperfusion syndromes.
Future Cardiol
December 2024
Cardiac Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, 00128, Italy.
Dysfunctions in miRNA production have been recently investigated as predictors of neoplasms and their therapeutic strategies. In this review, we summarize the available knowledge on miRNAs and cardiac tumors (such as myxoma) and mediastinal tumors (such as thymoma) and propose new avenues for future research. MiRNAs are crucial for cardiac development through the expression of cardiac transcription factors (miR-335-5p), hinder the cell cycle by modulating the activity of transcription factors (miR-126-3p, miR-320a), modulate the production of inflammatory factors such as interleukins (miR-217), and interfere with cell proliferation or apoptosis (miR-218, miR-634 and miR-122).
View Article and Find Full Text PDFAnn Transl Med
October 2024
Department of Cardiac Surgery, Centre Cardiologique du Nord, Saint-Denis, France.
Background And Objective: Surgery for mitral valve disease is a developing area with a wide range of surgical options. There is growing evidence on the best approach for secondary ischemic mitral regurgitation (SIMR) when the pathology is within the ventricle. The goal of this literature review is to provide a comprehensive comparison of surgical treatments for SIMR.
View Article and Find Full Text PDFJ Am Soc Echocardiogr
November 2024
Department of Cardiology, Hôpital Tenon and Hôpital Saint-Antoine, AP-HP, Sorbonne Université, Paris, France; Unité INSERM UMRS 1166 "Unité de recherche sur les maladies cardiovasculaires, du métabolisme et de la nutrition", Institut Hospitalo-Universitaire, Institut de Cardiométabolisme et Nutrition (ICAN), Sorbonne Université, Paris, France.
J Cardiovasc Dev Dis
October 2024
Department of Cardiothoracic Surgery, Royal Brompton and Harefield Hospitals, Sydney St., London SW3 6NP, UK.
Bicuspid aortic valve disease is the most prevalent congenital heart disease, affecting up to 2% of the general population. The presentation of symptoms may vary based on the patient's anatomy of fusion, with transthoracic echocardiography being the primary diagnostic tool. Bicuspid aortic valves may also appear with concomitant aortopathy, featuring fundamental structural changes which can lead to valve dysfunction and/or aortic dilatation over time.
View Article and Find Full Text PDFClin Cancer Res
October 2024
Institut Gustave Roussy, Villejuif, France.
Sci Rep
October 2024
Department of Anesthesia, Centre Cardiologique du Nord de Saint-Denis, Paris, France.
Echocardiography
October 2024
Cardiology Department, Centre Cardiologique du Nord, Saint-Denis, France.
Europace
November 2024
Service de Cardiologie et Maladies Vasculaires, CHRU Hopital de Pontchaillou, Rennes, France.
Arch Cardiovasc Dis
October 2024
Department of Cardiology, CHU Rennes, University of Rennes, INSERM, LTSI - UMR 1099, 35000 Rennes, France. Electronic address:
Diagnostics (Basel)
September 2024
Department of Medical Oncology and Clinical Research Unit, Military Hospital Bégin, 94160 Saint-Mandé, France.
The advent of immune checkpoint inhibitors (ICIs) has revolutionized the treatment paradigm of lung cancer, resulting in notable enhancements in patient survival. Nevertheless, evaluating treatment response in patients undergoing immunotherapy poses distinct challenges due to unconventional response patterns like pseudoprogressive disease (PPD), dissociated response (DR), and hyperprogressive disease (HPD). Conventional response criteria such as the RECIST 1.
View Article and Find Full Text PDFEur Heart J
November 2024
Department of Cardiology, CHRU-Nancy, Université de Lorraine, Nancy, 1 rue du Morvan, 54500 Vandoeuvre-lès-Nancy, France.
Background And Aims: Prophylactic implantable cardioverter-defibrillators (ICDs) are not recommended until left ventricular ejection fraction (LVEF) has been reassessed 40 to 90 days after an acute myocardial infarction. In the current therapeutic era, the prognosis of sustained ventricular arrhythmias (VAs) occurring during this early post-infarction phase (i.e.
View Article and Find Full Text PDFJ Thorac Dis
August 2024
Department of Cardiac Surgery, Centre Cardiologique du Nord, Saint-Denis, France.
Functional or secondary mitral regurgitation (MR) is a clear and present danger to cardiovascular health, with heightened morbidity and mortality rates. Secondary MR is caused by an imbalance between two sets of forces. There are two forces at play here.
View Article and Find Full Text PDFJ Cardiothorac Surg
September 2024
Department of Cardiothoracic Surgery, University of Cincinnati College of Medicine, Cincinnati, OH, 45267-0558, USA.
J Cardiothorac Vasc Anesth
November 2024
Department of Cardiology, Centre Cardiologique du Nord, Saint Denis, France.